-
-
Targeted Anti-Epidemic Support, Fosun Foundation Delivers the First Batch of Anti-epidemic Materials to Grassroots Families in Hong Kong
2022-03-02
(2 March 2022, Hong Kong) “Let’s Work Hand in Hand and Combat the Epidemic Together”. In an effort to support Hong Kong’s fightagainst the COVID-19 epidemic, Fosun Foundation urgently deployed the first batch anti-epidemic materials including 250,000 sets of COVID-19 rapid antigen test kits and 50,000 pieces of N95 respirators to Hong Kong. The first batch
-
-
汉利康Ⓡ Approved by NMPA for New Indication Differentiated Strategy Benefits a Wider Patient Population
2022-03-01
汉利康Ⓡ Approved by NMPA for New IndicationDifferentiated Strategy Benefits a Wider Patient PopulationShanghai, China, March1st, 2022 – Shanghai Henlius Biotech, Inc. (2696. HK) today announced that 汉利康® (rituximab injection), its first independently developed monoclonal antibody, has been granted approval by the National Medical Products Administration (NMPA) in
-
-
Fosun Foundation’s First Batch of 250,000 Sets of COVID-19 Rapid Antigen Test Kits Arrives in Hong Kong
2022-02-25
Hong Kong, 25 February 2022 – In an effort to support Hong Kong’s fight against the severe fifth wave of COVID-19 epidemic, Fosun Foundation announced last week the donation of HK$10 million anti-epidemic materials, including COVID-19 rapid antigen test kits and face masks to Hong Kong. The first batch of 250,000 sets of COVID-19 rapid antigen test kits arrived in Hong Kong from Shanghai this morning, and 50,000 pieces of N95 respirators are expected to be arrived in Hong Kong tomorrow morning.
-
-
Henlius Entered into a Collaboration with Getz Pharma to Commercialise Adalimumab Biosimilar 汉达远, Covering 11 Emerging Markets in Asia, Africa and Europe
2022-02-23
Shanghai, China, 23rd February, 2022 - Shanghai Henlius Biotech, Inc. (2696.HK) announced that the Company has entered into a licensing and supply agreement with Getz Pharma (Private) Limited and its affiliated company, Getz Pharma International FZ -LLC (together, “Getz Pharma”), pursuant to which, the company agreed to grant a license to Getz Pharma to commercialise adalimumab biosimilar 汉达远® in Islamic Republic of Pakistan, the Philippines, Vietnam, Cambodia, Myanmar, Nigeria, Kenya, Sri Lanka, Ukraine, Kazakhstan and Uzbekistan, and any other territories to be mutually agreed.
-
-
Fosun Foundation Donates First Batch of HK $10 Million Anti-epidemic Materials to Hong Kong
2022-02-19
The severe fifth wave of epidemic in Hong Kong has led the number of confirmed cases surge to record highs for days. In order to support Hong Kong’s fight against the epidemic, Fosun Foundation announced today that it will donate HK$10 million anti-epidemic materials, including COVID-19 rapid antigen test kits and surgical face masks to Hong Kong.As the fifth wave of epidemic
-
-
Fosun Establishes Consumer Technology Fund, Building Shanghai into a “City of Design”
2022-02-18
On 17 February, Shanghai World-class “City of Design” Development Promotion Conference was held at the Friendship Hall. Gong Zheng, Deputy Secretary of the CPC Shanghai Municipal Committee and Mayor of Shanghai opened a new chapter for Shanghai World-class “City of Design” Development. Zhang Wei, Vice Mayor of Shanghai delivered a speech
-
-
Fosun Tourism delivered outstanding performance during the Chinese New Year Holiday, High-quality products lead new trends in ice, snow and island vacations
2022-02-10
(Hong Kong, 9 February 2022) - Fosun Tourism Group ("Fosun Tourism" or the "Group", HKEX stock code: 1992), one of the world's leading leisure-focused integrated tourism enterprises, is pleased to announce that during the 2022 Chinese New Year Holiday – with the overall recovery of the industry still weak due to the resurgence of COVID-19 and
-
-
Fosun to Build a “Coastal City Parlor” in the Shanghai Bay Area
2022-02-09
On 7 February, Fosun and Jinshan District entered into an “Investment Cooperation Agreement” of the core area of Shanghai Jinshan Coastal International Cultural Tourist Resort.Chen Tong, Vice Mayor of Shanghai, Shang Yuying, Vice Secretary General of the Shanghai Municipal Government, Liu Jian, Secretary of the Jinshan District Committee, Fang Shizhong
-
-
Lage of Wolves Voted January's Manager of the Month
2022-02-04
Bruno Lage has won the Premier League Manager of the Month award for January following three top-flight wins from three to kick start 2022.